Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 264

1.

Harnessing Big Data for Health Care and Research: Are Urologists Ready?

Ghani KR, Zheng K, Wei JT, Friedman CP.

Eur Urol. 2014 Aug 11. pii: S0302-2838(14)00684-8. doi: 10.1016/j.eururo.2014.07.032. [Epub ahead of print]

PMID:
25123321
[PubMed - as supplied by publisher]
2.

Clinicopathological features and prognostic factors of young breast cancers in Eastern Guangdong of China.

Wei JT, Huang WH, Du CW, Qiu SQ, Wei XL, Liu J, Zhang GJ.

Sci Rep. 2014 Jun 19;4:5360. doi: 10.1038/srep05360.

PMID:
24942640
[PubMed - in process]
3.

Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer.

Ankerst DP, Hoefler J, Bock S, Goodman PJ, Vickers A, Hernandez J, Sokoll LJ, Sanda MG, Wei JT, Leach RJ, Thompson IM.

Urology. 2014 Jun;83(6):1362-7. doi: 10.1016/j.urology.2014.02.035.

PMID:
24862395
[PubMed - indexed for MEDLINE]
4.

Baseline characteristics predict risk of progression and response to combined medical therapy for benign prostatic hyperplasia (BPH).

Kozminski MA, Wei JT, Nelson J, Kent DM.

BJU Int. 2014 May 13. doi: 10.1111/bju.12802. [Epub ahead of print]

PMID:
24825577
[PubMed - as supplied by publisher]
5.

Variation in Use of Active Surveillance among Men Undergoing Expectant Treatment for Early Stage Prostate Cancer.

Filson CP, Schroeck FR, Ye Z, Wei JT, Hollenbeck BK, Miller DC.

J Urol. 2014 Feb 8. pii: S0022-5347(14)00230-4. doi: 10.1016/j.juro.2014.01.105. [Epub ahead of print]

PMID:
24518783
[PubMed - as supplied by publisher]
6.

A screening tool for clinically relevant urinary incontinence.

Suskind AM, Dunn RL, Morgan DM, Delancey JO, Rew KT, Wei JT.

Neurourol Urodyn. 2014 Jan 25. doi: 10.1002/nau.22564. [Epub ahead of print]

PMID:
24464849
[PubMed - as supplied by publisher]
7.

Complex cellular composition of solitary fibrous tumor of the prostate.

Gharaee-Kermani M, Mehra R, Robinson DR, Wei JT, Macoska JA.

Am J Pathol. 2014 Mar;184(3):732-9. doi: 10.1016/j.ajpath.2013.11.024. Epub 2014 Jan 13.

PMID:
24434011
[PubMed - in process]
8.

Satisfaction with information used to choose prostate cancer treatment.

Gilbert SM, Sanda MG, Dunn RL, Greenfield TK, Hembroff L, Klein E, Saigal CS, Pisters L, Michalski J, Sandler HM, Litwin MS, Wei JT.

J Urol. 2014 May;191(5):1265-71. doi: 10.1016/j.juro.2013.12.008. Epub 2013 Dec 12.

PMID:
24333514
[PubMed - indexed for MEDLINE]
9.

Trends in medical management of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

Filson CP, Wei JT, Hollingsworth JM.

Urology. 2013 Dec;82(6):1386-92. doi: 10.1016/j.urology.2013.07.062. Epub 2013 Oct 23.

PMID:
24269224
[PubMed - indexed for MEDLINE]
10.

Evaluating long-term patient-centered outcomes following prostate cancer treatment: findings from the Michigan Prostate Cancer Survivor study.

Darwish-Yassine M, Berenji M, Wing D, Copeland G, Demers RY, Garlinghouse C, Fagerlin A, Newth GE, Northouse L, Holmes-Rovner M, Rovner D, Sims J, Wei JT.

J Cancer Surviv. 2014 Mar;8(1):121-30. doi: 10.1007/s11764-013-0312-8. Epub 2013 Nov 10.

PMID:
24214413
[PubMed - in process]
11.

Survivorship after prostate cancer treatment: spouses' quality of life at 36 months.

Harden J, Sanda MG, Wei JT, Yarandi HN, Hembroff L, Hardy J, Northouse L.

Oncol Nurs Forum. 2013 Nov;40(6):567-73. doi: 10.1188/13.ONF.567-573.

PMID:
24161635
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

How much worse will my voiding symptoms get over time?

Wei JT.

J Urol. 2014 Jan;191(1):15-6. doi: 10.1016/j.juro.2013.10.047. Epub 2013 Oct 15. No abstract available.

PMID:
24139789
[PubMed - indexed for MEDLINE]
13.

Neoadjuvant androgen deprivation therapy leads to immediate impairment of vitality/hormonal and sexual quality of life: results of a multicenter prospective study.

Gay HA, Michalski JM, Hamstra DA, Wei JT, Dunn RL, Klein EA, Sandler HM, Saigal C, Litwin M, Kuban D, Hembroff L, Chang P, Sanda MG; PROSTQA Consortium.

Urology. 2013 Dec;82(6):1363-8. doi: 10.1016/j.urology.2013.06.062. Epub 2013 Oct 16.

PMID:
24139340
[PubMed - indexed for MEDLINE]
14.

Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice.

Chipman JJ, Sanda MG, Dunn RL, Wei JT, Litwin MS, Crociani CM, Regan MM, Chang P; PROST-QA Consortium.

J Urol. 2014 Mar;191(3):638-45. doi: 10.1016/j.juro.2013.09.040. Epub 2013 Sep 25.

PMID:
24076307
[PubMed - indexed for MEDLINE]
15.

Reply by the authors.

Schroeck FR, Wei JT.

Urology. 2013 Oct;82(4):981. doi: 10.1016/j.urology.2013.06.001. No abstract available.

PMID:
24075001
[PubMed - indexed for MEDLINE]
16.

Evaluation of tissue PCA3 expression in prostate cancer by RNA in situ hybridization--a correlative study with urine PCA3 and TMPRSS2-ERG.

Warrick JI, Tomlins SA, Carskadon SL, Young AM, Siddiqui J, Wei JT, Chinnaiyan AM, Kunju LP, Palanisamy N.

Mod Pathol. 2014 Apr;27(4):609-20. doi: 10.1038/modpathol.2013.169. Epub 2013 Sep 27.

PMID:
24072184
[PubMed - in process]
17.

The Michigan incontinence symptom index (M-ISI): A clinical measure for type, severity, and bother related to urinary incontinence.

Suskind AM, Dunn RL, Morgan DM, DeLancey JO, McGuire EJ, Wei JT.

Neurourol Urodyn. 2014 Sep;33(7):1128-34. doi: 10.1002/nau.22468. Epub 2013 Aug 14.

PMID:
23945994
[PubMed - in process]
18.

A novel protein from Eupolyphaga sinensis inhibits adhesion, migration, and invasion of human lung cancer A549 cells.

Wang FX, Wu N, Wei JT, Liu J, Zhao J, Ji AG, Lin XK.

Biochem Cell Biol. 2013 Aug;91(4):244-51. doi: 10.1139/bcb-2013-0002. Epub 2013 Mar 28.

PMID:
23859019
[PubMed - indexed for MEDLINE]
19.

Use of advanced treatment technologies among men at low risk of dying from prostate cancer.

Jacobs BL, Zhang Y, Schroeck FR, Skolarus TA, Wei JT, Montie JE, Gilbert SM, Strope SA, Dunn RL, Miller DC, Hollenbeck BK.

JAMA. 2013 Jun 26;309(24):2587-95. doi: 10.1001/jama.2013.6882.

PMID:
23800935
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The efficacy and safety of combined therapy with α-blockers and anticholinergics for men with benign prostatic hyperplasia: a meta-analysis.

Filson CP, Hollingsworth JM, Clemens JQ, Wei JT.

J Urol. 2013 Dec;190(6):2153-60. doi: 10.1016/j.juro.2013.05.058. Epub 2013 May 30.

PMID:
23727412
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk